ICU Medical, Rating Increased to Outperform at Raymond James (ICUI)
ICU Medical, (NASDAQ:ICUI) was upgraded by stock analysts at Raymond James from a “market perform” rating to an “outperform” rating in a report issued on Tuesday, TheFlyOnTheWall.com reports. The firm currently has a $67.00 target price on the stock. Raymond James’ price objective points to a potential upside of 15.74% from the company’s current price. The analysts noted that the move was a valuation call.
In other ICU Medical, news, Director George A. Lopez sold 12,750 shares of the company’s stock on the open market in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $57.85, for a total value of $737,587.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of ICU Medical, (NASDAQ:ICUI) opened at 57.89 on Tuesday. ICU Medical, has a 52 week low of $54.00 and a 52 week high of $74.93. The stock has a 50-day moving average of $59.7 and a 200-day moving average of $59.73. The company has a market cap of $880.4 million and a P/E ratio of 23.01.
ICU Medical, (NASDAQ:ICUI) last issued its quarterly earnings data on Monday, August 11th. The company reported $0.38 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.34 by $0.04. The company had revenue of $78.70 million for the quarter, compared to the consensus estimate of $74.13 million. During the same quarter last year, the company posted $0.48 earnings per share. ICU Medical,’s revenue was up .1% compared to the same quarter last year. On average, analysts predict that ICU Medical, will post $1.39 earnings per share for the current fiscal year.
ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.